UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 90

Sortiert nach

Reductions in insulin resistance are mediated primarily via weight loss in subjects with type 2 diabetes on semaglutide

The journal of clinical endocrinology and metabolism, 2019-09, Vol.104 (9), p.4078-4086

2019

Link zum Volltext

Verfügbarkeit prüfen

Estimation of Long‐Term Efficacy of Denosumab Treatment in Postmenopausal Women With Osteoporosis: A FRAX‐ and Virtual Twin‐Based Post Hoc Analysis From the FREEDOM and FREEDOM Extension Trials

JBMR plus, 2020-04, Vol.4 (4), p.e10348-n/a

2020

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of osteoporosis, vertebral fractures and hypovitaminosis D in postmenopausal women living in a rural environment

Maturitas, 2014-03, Vol.77 (3), p.282-286

2014

Link zum Volltext

Verfügbarkeit prüfen

Use of Tirzepatide in Adults with Type 2 Diabetes Mellitus: Scientific Evidence and Practical Aspects

Diabetes therapy, 2024-07, Vol.15 (7), p.1501-1512

2024

Link zum Volltext

Verfügbarkeit prüfen

Identifying and Managing Patients at High Risk for Fractures: Conclusions from the Second Spanish Multidisciplinary Forum—Parathyroid Hormone Use in Osteoporotic Patients at High Risk for Fractures

Drugs in R&D, 2012-12, Vol.12 (4), p.199-206

Gimeno, Esteban Jódar

2012

Link zum Volltext

Verfügbarkeit prüfen

Is vitamin-D supplementation not useful in patients at risk of fractures and falls?

Gynecological endocrinology, 2020-02, Vol.36 (2), p.93-95

2020

Link zum Volltext

Verfügbarkeit prüfen

Document on a comprehensive approach to type 2 diabetes mellitus

Endocrinologia, diabetes y nutricion, 2019-08, Vol.66 (7), p.443-458

2019

Link zum Volltext

Verfügbarkeit prüfen

Guide of management of alterations in mineral and bone metabolism during gestation and lactation

Endocrinología, diabetes y nutrición., 2022-08, Vol.69 (7), p.530-539

2022

Link zum Volltext

Verfügbarkeit prüfen

Phosphate disorders and clinical management of hypophosphatemia and hyperphosphatemia

Endocrinologia, diabetes y nutricion, 2020-03, Vol.67 (3), p.205-215

2020

Link zum Volltext

Verfügbarkeit prüfen

Recommended vitamin D levels in the general population

Endocrinologia, diabetes y nutricion, 2017-03, Vol.64, p.7-14

2017

Link zum Volltext

Verfügbarkeit prüfen

Romosozumab efficacy and safety in European patients enrolled in the FRAME trial

Osteoporosis international, 2022-12, Vol.33 (12), p.2527-2536

2022

Link zum Volltext

Verfügbarkeit prüfen

Consensus document on osteoporosis in males

Endocrinologia, diabetes y nutricion, 2018-03, Vol.65, p.9-16

2018

Link zum Volltext

Verfügbarkeit prüfen

Effect of Liraglutide on Cardiovascular Outcomes in Elderly Patients: A Post Hoc Analysis of a Randomized Controlled Trial

Annals of internal medicine, 2019-03, Vol.170 (6), p.423

2019

Link zum Volltext

Verfügbarkeit prüfen

Full length parathyroid hormone (1-84) in the treatment of osteoporosis in postmenopausal women

Clinical interventions in aging, 2007-01, Vol.2 (1), p.163-174

Jódar-Gimeno, Esteban

2007

Link zum Volltext

Verfügbarkeit prüfen

Liraglutide in the treatment of Type 2 diabetes: clinical data and practical considerations for its use

Expert review of endocrinology & metabolism, 2010-11, Vol.5 (6), p.799-807

2010

Link zum Volltext

Verfügbarkeit prüfen

Ketoconazole therapy: hormonal and clinical effects in non-tumoral hyperandrogenism

European journal of endocrinology, 1994-04, Vol.130 (4), p.333

1994

Link zum Volltext

Verfügbarkeit prüfen

Recommendations on the effect of antidiabetic drugs in bone

Endocrinologia, diabetes y nutricion, 2017-03, Vol.64, p.1-6

2017

Link zum Volltext

Verfügbarkeit prüfen

Guía de manejo de las alteraciones del metabolismo mineral y óseo en la gestación y la lactancia

Endocrinología, diabetes y nutrición, 2022-08, Vol.69 (7), p.530-539

2022

Link zum Volltext

Verfügbarkeit prüfen

Connected Insulin Pens and Caps: An Expert’s Recommendation from the Area of Diabetes of the Spanish Endocrinology and Nutrition Society (SEEN)

Diabetes therapy, 2023-07, Vol.14 (7), p.1077-1091

2023

Link zum Volltext

Verfügbarkeit prüfen

Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial

The Lancet (British edition), 2017-09, Vol.390 (10102), p.1585-1594

2017

Link zum Volltext

Verfügbarkeit prüfen

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

The Lancet (British edition), 2018-10, Vol.392 (10157), p.1519-1529

2018

Link zum Volltext

Verfügbarkeit prüfen

Mitochondrial plasticity as a key determinant for CVD risk in T2D

Free radical biology & medicine, 2023-05, Vol.201, p.58-59

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 90

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(53)
Mit Volltextzugriff
(78)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(32)
Life Sciences & Biomedicine
(32)
Science & Technology
(32)
Endocrinology & Metabolism
(27)
Osteoporosis
(20)
Female
(17)
Endocrinology And Metabolism
(15)
Fractures
(14)
Male
(14)
Aged
(13)
Diabetes Mellitus
(13)
Nutrition & Dietetics
(11)
Fracturas
(10)
Middle Aged
(10)
Bone Density
(8)
Diabetes
(8)
Diabetes Mellitus, Type 2 - Drug Therapy
(8)
Endocrinology
(8)
Hypoglycemia
(8)
Clinical Trials
(7)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Reductions in insulin resistance are mediated primarily via weight loss in subjects with type 2 diabetes on semaglutide

Estimation of Long‐Term Efficacy of Denosumab Treatment in Postmenopausal Women With Osteoporosis: A FRAX‐ and Virtual Twin‐Based Post Hoc Analysis From the FREEDOM and FREEDOM Extension Trials

Prevalence of osteoporosis, vertebral fractures and hypovitaminosis D in postmenopausal women living in a rural environment

Use of Tirzepatide in Adults with Type 2 Diabetes Mellitus: Scientific Evidence and Practical Aspects

Identifying and Managing Patients at High Risk for Fractures: Conclusions from the Second Spanish Multidisciplinary Forum—Parathyroid Hormone Use in Osteoporotic Patients at High Risk for Fractures

Is vitamin-D supplementation not useful in patients at risk of fractures and falls?

Document on a comprehensive approach to type 2 diabetes mellitus

Guide of management of alterations in mineral and bone metabolism during gestation and lactation

Comprehensive approach to people with type 2 diabetes. Diabetes Knowledge Area of the Spanish Society of Endocrinology and Nutrition

Phosphate disorders and clinical management of hypophosphatemia and hyperphosphatemia

Executive summary: Position document: Evaluation and management of hypoglycemia in the patient with diabetes mellitus 2020. Diabetes Mellitus Working Group of the Spanish Society of Endocrinology and Nutrition

Recommended vitamin D levels in the general population

Romosozumab efficacy and safety in European patients enrolled in the FRAME trial

Consensus document on osteoporosis in males

Effect of Liraglutide on Cardiovascular Outcomes in Elderly Patients: A Post Hoc Analysis of a Randomized Controlled Trial

Full length parathyroid hormone (1-84) in the treatment of osteoporosis in postmenopausal women

Liraglutide in the treatment of Type 2 diabetes: clinical data and practical considerations for its use

Ketoconazole therapy: hormonal and clinical effects in non-tumoral hyperandrogenism

Recommendations on the effect of antidiabetic drugs in bone

Guía de manejo de las alteraciones del metabolismo mineral y óseo en la gestación y la lactancia

Connected Insulin Pens and Caps: An Expert’s Recommendation from the Area of Diabetes of the Spanish Endocrinology and Nutrition Society (SEEN)

Abordaje integral de las personas con diabetes tipo 2. Área de Conocimiento de Diabetes de la Sociedad Española de Endocrinología y Nutrición

Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Mitochondrial plasticity as a key determinant for CVD risk in T2D

Suchergebnisse filtern